Ana Dordea Nicholson

Ana Dordea Nicholson, PhD has a diverse work experience in the field of biomedicine and strategy. Ana is currently serving as the Director of R&D Strategy at Generate Biomedicines, Inc. Prior to this, they worked at Boston Consulting Group (BCG) as a Project Leader with a focus on R&D and commercial strategy in the biopharma industry. Ana also gained experience in European operations through their work with UK/Italian large Biopharma Organizations and German health insurance providers.

Before joining BCG, Ana had a fellowship at The Boston Consulting Group. Ana also worked as a Postdoctoral Research Fellow at Harvard Medical School/Massachusetts General Hospital and Massachusetts General Hospital, where their research was focused on anesthesia, critical care, and pain medicine. Ana began their career as a Ph.D. Candidate at Newcastle University Medical School, specializing in cellular medicine.

Overall, Ana Dordea Nicholson, PhD has demonstrated expertise in R&D strategy, operational optimization, and clinical development across multiple organizations in the biopharma sector.

Ana Dordea Nicholson obtained their education in a concise and chronological manner. Ana completed their scientific specialty with a biology sub-specialty at Lycee International from 1992 to 2004, earning a French "Baccalauréat général" and a German "Abitur". Following this, from 2004 to 2008, they attended The University of Sheffield, Department of Molecular Biology and Biotechnology, where they obtained an M.Biol.Sci. degree in Medical Biochemistry. Lastly, from 2008 to 2012, Ana pursued their Doctor of Philosophy (Ph.D.) in Vascular Physiology at Newcastle University, Reproductive and Vascular Biology School, Institute of Cellular Medicine, Faculty of Medical Sciences.